Gentiva Health Services Inc.
) reported first-quarter 2013 operating earnings of 23 cents per
share, which lagged the Zacks Consensus Estimate of 31 cents as
well as the year-ago quarter level of 24 cents per share.
Operating income of $7.1 million also declined from $7.4 million
in the year-ago quarter.
Including a non-cash impairment charge of $224.3 million related
to goodwill and other long-lived assets, along with
restructuring, legal settlement and acquisition and integration
costs of $0.14 million, Gentiva posted a net loss of $207.2
million or $6.73 per share, compared with net income of $4.8
million or 16 cents per share in the first quarter of 2012.
Gentiva's net revenue declined 5% year over year to $415.6
million from $435.7 million in the year-ago quarter. Net revenue
also missed the Zacks Consensus Estimate of $428 million. The
year-over-year decline was largely due to a significant cut in
the home health Medicare rates along with the impact of
sequestration and sale and closure of some branches.
Home Health Episodic
segment revenues declined 2% year over year to $207.4 million.
segment revenues declined 8% year over year to $179.5 million.
Adjusted earnings before interest, taxes, depreciation and
amortization (EBITDA) attributable to continuing operations
decreased 6.7% to $39.1 million from $41.9 million in the
Gentiva exited the reported quarter with cash and cash
equivalents of approximately $159.6 million, down from $207.1
million as of Dec 31, 2012. Outstanding debt was $910.2 million,
down from $935.2 million at 2012 end.
During the reported quarter, net cash used in operating
activities amounted to $20.6 million, narrower than the cash
outflow of $34.7 million in the prior-year period. Free cash flow
also narrowed to ($23.3) million from ($38.5) million in the
first-quarter of 2012.
As of Mar 31, 2013, Gentiva had total assets of $1.24 billion and
shareholder equity of $29.6 million, as compared with $1.51
billion and $234.7 million, respectively, as of Dec 31, 2012.
Gentiva's net revenue guidance for 2013 stands at $1.69-$1.73
billion. This guidance includes a negative impact of $21 million
from the sale and closure of branches in 2012. The company
expects adjusted income from continuing operations between 90
cents and $1.10 per share, calculated on the basis of 31 million
Gentiva carries a Zacks Rank #5 (Strong Sell). Another healthcare
DaVita HealthCare Partners Inc.
) reported first-quarter 2013 operating earnings of $1.84 per
share, beating the Zacks Consensus Estimate of $1.78 as well as
$1.50 per share reported in the prior-year quarter.
Other healthcare companies worth considering are
Addus HomeCare Corporation
). Both these companies carry a Zacks Rank #1 (Strong Buy).
ADDUS HOMECARE (ADUS): Free Stock Analysis
DAVITA INC (DVA): Free Stock Analysis Report
GENTIVA HEALTH (GTIV): Free Stock Analysis
HEALTHSOUTH CP (HLS): Free Stock Analysis
To read this article on Zacks.com click here.